Chen Schor - 14 Aug 2023 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Aug 2023, 18:11:59 UTC
Prior SEC filing
25 May 2023
Next SEC filing
02 Oct 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nick Harvey, Attorney-in-Fact

Key filing fact

Chen Schor filed Form 4 for Adicet Bio, Inc. (ACET) on 16 Aug 2023.

Key facts

  • This page summarizes Chen Schor's Form 4 filing for Adicet Bio, Inc. (ACET).
  • 12 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 16 Aug 2023, 18:11.

Change

  • Previous filing in this sequence was filed on 25 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACET transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-36,857
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
36,857
Exercise price
$8.89
Footnotes
F1, F2, F3
ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+36,857
Change %
Price
$0.000000
Shares after
36,857
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
36,857
Exercise price
$2.14
Footnotes
F2, F3, F4
ACET transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-872,111
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
872,111
Exercise price
$16.11
Footnotes
F2, F5
ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+872,111
Change %
Price
$0.000000
Shares after
872,111
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
872,111
Exercise price
$2.14
Footnotes
F2, F4, F5
ACET transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-240,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
240,000
Exercise price
$13.27
Footnotes
F2, F6
ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+240,000
Change %
Price
$0.000000
Shares after
240,000
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
240,000
Exercise price
$2.14
Footnotes
F2, F4, F6
ACET transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-421,600
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
421,600
Exercise price
$16.82
Footnotes
F2, F7
ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+421,600
Change %
Price
$0.000000
Shares after
421,600
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
421,600
Exercise price
$2.14
Footnotes
F2, F4, F7
ACET transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-295,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
295,000
Exercise price
$15.52
Footnotes
F2, F8
ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+295,000
Change %
Price
$0.000000
Shares after
295,000
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
295,000
Exercise price
$2.14
Footnotes
F2, F4, F8
ACET transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
-384,900
Change %
-100%
Price
$0.000000*
Shares after
0
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
384,900
Exercise price
$9.05
Footnotes
F2, F9
ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+384,900
Change %
Price
$0.000000
Shares after
384,900
Date
14 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
384,900
Exercise price
$2.14
Footnotes
F2, F4, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Reflects 1-for-7 reverse stock split effected by the Issuer on September 15, 2020.

Footnote F2

On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 14, 2023 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

Footnote F3

The shares subject to this option are fully vested and exercisable as of the date hereof.

Footnote F4

The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.

Footnote F5

The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following September 17, 2020, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

Footnote F6

The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 13, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

Footnote F7

The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following February 12, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

Footnote F8

The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 7, 2022, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

Footnote F9

The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 24, 2023, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .